Compare NRDY & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRDY | CLNN |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 127.9M | 120.6M |
| IPO Year | N/A | N/A |
| Metric | NRDY | CLNN |
|---|---|---|
| Price | $1.02 | $5.02 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $1.25 | ★ $32.67 |
| AVG Volume (30 Days) | ★ 1.2M | 105.6K |
| Earning Date | 02-26-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $177,867,000.00 | $214,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.16 | $82.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.77 | $2.28 |
| 52 Week High | $2.02 | $13.50 |
| Indicator | NRDY | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 41.81 | 34.95 |
| Support Level | $1.00 | $4.50 |
| Resistance Level | $1.07 | $5.43 |
| Average True Range (ATR) | 0.06 | 0.60 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 12.79 | 24.77 |
Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its proprietary platform leverages technology, including artificial intelligence ("AI"), to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals. The company provides learning experiences across numerous subjects and multiple formats, including one-on-one instruction, small group tutoring, large format classes, tutor chat, essay review, adaptive assessments, and self-study tools. The company generates revenue by selling services to learners and institutions for one-on-one instruction and small group tutoring.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.